The expression level of CCAT2 was associated in several cases with chemotherapeutic and radiotherapeutic resistance in gliomas, CRC, thyroid, breast, and esophageal cancers [32,59,89,123,124]. The gene discussed is CCAT2; the disease is colorectal carcinoma.